&nbsp;

GEMCNPAC(W).pdf

May 2020

Document

GEMCNPAC(W)-FR.pdf

Jun 2020

Document

tomMcHughProfile.png

Dec 2020

Regimen

GEMOD

Cancer Type:

Hematologic,

Lymphoma - T-cell

Intent: Adjuvant, Curative, Palliative

Funding:

ODB - General Benefit

dexamethasone

Drugs Used:

Quick Link(s):

Regimen Monograph

Dec 2020

Regimen

GEMOX

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's High Grade,

Lymphoma - Non-Hodgkin's Intermediate Grade

Intent: Palliative, Curative, Adjuvant

Drugs Used:

gemcitabine,

oxaliplatin

Quick Link(s):

Regimen Monograph

Dec 2020

Regimen

GEMOX+RITU

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's High Grade,

Lymphoma - Non-Hodgkin's Intermediate Grade

Intent: Palliative, Curative, Adjuvant

Drugs Used:

riTUXimab (Unfunded),

gemcitabine,

oxaliplatin,

riTUXimab (subcut) (Unfunded)

Quick Link(s):

Regimen Monograph

Feb 2021

Regimen

GEMOX

Cancer Type:

Endocrine,

Thyroid

Intent: Palliative

Drugs Used:

gemcitabine,

oxaliplatin

Quick Link(s):

Regimen Monograph

Dec 2020

Tumeurs neuroendocriniennes (TNE)

Document

TobaccoWiseFNIMBrochureMetis.pdf

Jan 2021

Document

TobaccoWiseFNIMBrochureMetis-FR.pdf

Jan 2021

Regimen

TRAS

Cancer Type:

Gynecologic,

Endometrial

Intent: Palliative, Curative

Funding:

New Drug Funding Program

Trastuzumab (Biosimilar) - Advanced or Recurrent Endometrial Cancer

Drugs Used:

trastuzumab